Author Description

This report provides: An overview of the global market for drugs and diagnostics for hematological disorders. Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020. A breakdown of the market by hematological diseases, hematological cancers, and hematological diagnostics. A review of blood cancers, such as various types of leukemia, lymphoma, and myeloma, and their therapies. Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities. Delineation of drugs approved by the FDA for hematological disorders. Profiles of key companies in the industry.